Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 48 entries
Sorted by: Best Match Show Resources per page
A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer's disease treated with rivastigmine transdermal patch.

SAGE open medicine

Vagenas V, Vlachos GS, Vlachou N, Liakopoulos D, Kalaitzakis ME, Vikelis M.
PMID: 26770787
SAGE Open Med. 2015 Jun 03;3:2050312115587795. doi: 10.1177/2050312115587795. eCollection 2015.

OBJECTIVES: The primary objective of this multicentre, prospective, observational study was to assess whether there is improvement in the patients' quality of life under treatment with rivastigmine transdermal patch, as it is evaluated both by patients and their caregivers....

Cite
Vagenas V, Vlachos GS, Vlachou N, et al. A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer's disease treated with rivastigmine transdermal patch. SAGE Open Med. 2015;3:2050312115587795doi: 10.1177/2050312115587795.
Vagenas, V., Vlachos, G. S., Vlachou, N., Liakopoulos, D., Kalaitzakis, M. E., & Vikelis, M. (2015). A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer's disease treated with rivastigmine transdermal patch. SAGE open medicine, 32050312115587795. https://doi.org/10.1177/2050312115587795
Vagenas, Vassileios, et al. "A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer's disease treated with rivastigmine transdermal patch." SAGE open medicine vol. 3 (2015): 2050312115587795. doi: https://doi.org/10.1177/2050312115587795
Vagenas V, Vlachos GS, Vlachou N, Liakopoulos D, Kalaitzakis ME, Vikelis M. A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer's disease treated with rivastigmine transdermal patch. SAGE Open Med. 2015 Jun 03;3:2050312115587795. doi: 10.1177/2050312115587795. eCollection 2015. PMID: 26770787; PMCID: PMC4679280.
Copy Download .nbib Format: NLM
Synthesis of cyclopent-2-enones from furans using a nebulizer-based continuous flow photoreactor.

Organic & biomolecular chemistry

Ioannou GI, Montagnon T, Kalaitzakis D, Pergantis SA, Vassilikogiannakis G.
PMID: 29177328
Org Biomol Chem. 2017 Dec 13;15(48):10151-10155. doi: 10.1039/c7ob02557b.

A series of hydroxycyclopent-2-enones and methoxycyclopent-2-enones have been synthesized in a single operation from simple furan substrates using an innovative continuous flow nebulizer system (NebPhotOX). Photooxygenation of the furan substrates takes place in an aerosol within the NebPhotOX system.

Cite
Ioannou GI, Montagnon T, Kalaitzakis D, et al. Synthesis of cyclopent-2-enones from furans using a nebulizer-based continuous flow photoreactor. Org Biomol Chem. 2017;15(48):10151-10155doi: 10.1039/c7ob02557b.
Ioannou, G. I., Montagnon, T., Kalaitzakis, D., Pergantis, S. A., & Vassilikogiannakis, G. (2017). Synthesis of cyclopent-2-enones from furans using a nebulizer-based continuous flow photoreactor. Organic & biomolecular chemistry, 15(48), 10151-10155. https://doi.org/10.1039/c7ob02557b
Ioannou, Georgios I, et al. "Synthesis of cyclopent-2-enones from furans using a nebulizer-based continuous flow photoreactor." Organic & biomolecular chemistry vol. 15,48 (2017): 10151-10155. doi: https://doi.org/10.1039/c7ob02557b
Ioannou GI, Montagnon T, Kalaitzakis D, Pergantis SA, Vassilikogiannakis G. Synthesis of cyclopent-2-enones from furans using a nebulizer-based continuous flow photoreactor. Org Biomol Chem. 2017 Dec 13;15(48):10151-10155. doi: 10.1039/c7ob02557b. PMID: 29177328.
Copy Download .nbib Format: NLM
A multi-institutional consensus on how to perform endoscopic ultrasound-guided peri-pancreatic fluid collection drainage and endoscopic necrosectomy.

Endoscopic ultrasound

Guo J, Saftoiu A, Vilmann P, Fusaroli P, Giovannini M, Mishra G, Rana SS, Ho S, Poley JW, Ang TL, Kalaitzakis E, Siddiqui AA, De La Mora-Levy JG, Lakhtakia S, Bhutani MS, Sharma M, Mukai S, Garg PK, Lee LS, Vila JJ, Artifon E, Adler DG, Sun S.
PMID: 29063871
Endosc Ultrasound. 2017 Sep-Oct;6(5):285-291. doi: 10.4103/eus.eus_85_17.

There is a lack of consensus on how endoscopic ultrasound (EUS)-guided pseudocyst drainage and endoscopic necrosectomy should be performed. This survey was carried out amongst members of the EUS Journal Editorial Board to describe their practices in performing this...

Cite
Guo J, Saftoiu A, Vilmann P, et al. A multi-institutional consensus on how to perform endoscopic ultrasound-guided peri-pancreatic fluid collection drainage and endoscopic necrosectomy. Endosc Ultrasound. 2017;6(5):285-291doi: 10.4103/eus.eus_85_17.
Guo, J., Saftoiu, A., Vilmann, P., Fusaroli, P., Giovannini, M., Mishra, G., Rana, S. S., Ho, S., Poley, J. W., Ang, T. L., Kalaitzakis, E., Siddiqui, A. A., De La Mora-Levy, J. G., Lakhtakia, S., Bhutani, M. S., Sharma, M., Mukai, S., Garg, P. K., Lee, L. S., Vila, J. J., Artifon, E., Adler, D. G., & Sun, S. (2017). A multi-institutional consensus on how to perform endoscopic ultrasound-guided peri-pancreatic fluid collection drainage and endoscopic necrosectomy. Endoscopic ultrasound, 6(5), 285-291. https://doi.org/10.4103/eus.eus_85_17
Guo, Jintao, et al. "A multi-institutional consensus on how to perform endoscopic ultrasound-guided peri-pancreatic fluid collection drainage and endoscopic necrosectomy." Endoscopic ultrasound vol. 6,5 (2017): 285-291. doi: https://doi.org/10.4103/eus.eus_85_17
Guo J, Saftoiu A, Vilmann P, Fusaroli P, Giovannini M, Mishra G, Rana SS, Ho S, Poley JW, Ang TL, Kalaitzakis E, Siddiqui AA, De La Mora-Levy JG, Lakhtakia S, Bhutani MS, Sharma M, Mukai S, Garg PK, Lee LS, Vila JJ, Artifon E, Adler DG, Sun S. A multi-institutional consensus on how to perform endoscopic ultrasound-guided peri-pancreatic fluid collection drainage and endoscopic necrosectomy. Endosc Ultrasound. 2017 Sep-Oct;6(5):285-291. doi: 10.4103/eus.eus_85_17. PMID: 29063871; PMCID: PMC5664848.
Copy Download .nbib Format: NLM
Overview of Cattle Diseases Listed Under Category C, D or E in the Animal Health Law for Which Control Programmes Are in Place Within Europe.

Frontiers in veterinary science

Hodnik JJ, Acinger-Rogić Ž, Alishani M, Autio T, Balseiro A, Berezowski J, Carmo LP, Chaligiannis I, Conrady B, Costa L, Cvetkovikj I, Davidov I, Dispas M, Djadjovski I, Duarte EL, Faverjon C, Fourichon C, Frössling J, Gerilovych A, Gethmann J, Gomes J, Graham D, Guelbenzu M, Gunn GJ, Henry MK, Hopp P, Houe H, Irimia E, Ježek J, Juste RA, Kalaitzakis E, Kaler J, Kaplan S, Kostoulas P, Kovalenko K, Kneževič N, Knific T, Koleci X, Madouasse A, Malakauskas A, Mandelik R, Meletis E, Mincu M, Mõtus K, Muñoz-Gómez V, Niculae M, Nikitović J, Ocepek M, Tangen-Opsal M, Ózsvári L, Papadopoulos D, Papadopoulos T, Pelkonen S, Polak MP, Pozzato N, Rapaliuté E, Ribbens S, Niza-Ribeiro J, Roch FF, Rosenbaum Nielsen L, Saez JL, Nielsen SS, van Schaik G, Schwan E, Sekovska B, Starič J, Strain S, Šatran P, Šerić-Haračić S, Tamminen LM, Thulke HH, Toplak I, Tuunainen E, Verner S, Vilček Š, Yildiz R, Santman-Berends IMGA.
PMID: 34395571
Front Vet Sci. 2021 Jul 30;8:688078. doi: 10.3389/fvets.2021.688078. eCollection 2021.

The COST action "Standardising output-based surveillance to control non-regulated diseases of cattle in the European Union (SOUND control)," aims to harmonise the results of surveillance and control programmes (CPs) for non-EU regulated cattle diseases to facilitate safe trade and...

Cite
Hodnik JJ, Acinger-Rogić Ž, Alishani M, et al. Overview of Cattle Diseases Listed Under Category C, D or E in the Animal Health Law for Which Control Programmes Are in Place Within Europe. Front Vet Sci. 2021;8:688078doi: 10.3389/fvets.2021.688078.
Hodnik, J. J., Acinger-Rogić, �. �., Alishani, M., Autio, T., Balseiro, A., Berezowski, J., Carmo, L. P., Chaligiannis, I., Conrady, B., Costa, L., Cvetkovikj, I., Davidov, I., Dispas, M., Djadjovski, I., Duarte, E. L., Faverjon, C., Fourichon, C., Frössling, J., Gerilovych, A., Gethmann, J., Gomes, J., Graham, D., Guelbenzu, M., Gunn, G. J., Henry, M. K., Hopp, P., Houe, H., Irimia, E., Ježek, J., Juste, R. A., Kalaitzakis, E., Kaler, J., Kaplan, S., Kostoulas, P., Kovalenko, K., Kneževič, N., Knific, T., Koleci, X., Madouasse, A., Malakauskas, A., Mandelik, R., Meletis, E., Mincu, M., Mõtus, K., Muñoz-Gómez, V., Niculae, M., Nikitović, J., Ocepek, M., Tangen-Opsal, M., Ózsvári, L., Papadopoulos, D., Papadopoulos, T., Pelkonen, S., Polak, M. P., Pozzato, N., Rapaliuté, E., Ribbens, S., Niza-Ribeiro, J., Roch, F. F., Rosenbaum Nielsen, L., Saez, J. L., Nielsen, S. S., van Schaik, G., Schwan, E., Sekovska, B., Starič, J., Strain, S., Šatran, P., Šerić-Haračić, S., Tamminen, L. M., Thulke, H. H., Toplak, I., Tuunainen, E., Verner, S., Vilček, �. �., Yildiz, R., & Santman-Berends, I. M. G. A. (2021). Overview of Cattle Diseases Listed Under Category C, D or E in the Animal Health Law for Which Control Programmes Are in Place Within Europe. Frontiers in veterinary science, 8688078. https://doi.org/10.3389/fvets.2021.688078
Hodnik, Jaka Jakob, et al. "Overview of Cattle Diseases Listed Under Category C, D or E in the Animal Health Law for Which Control Programmes Are in Place Within Europe." Frontiers in veterinary science vol. 8 (2021): 688078. doi: https://doi.org/10.3389/fvets.2021.688078
Hodnik JJ, Acinger-Rogić Ž, Alishani M, Autio T, Balseiro A, Berezowski J, Carmo LP, Chaligiannis I, Conrady B, Costa L, Cvetkovikj I, Davidov I, Dispas M, Djadjovski I, Duarte EL, Faverjon C, Fourichon C, Frössling J, Gerilovych A, Gethmann J, Gomes J, Graham D, Guelbenzu M, Gunn GJ, Henry MK, Hopp P, Houe H, Irimia E, Ježek J, Juste RA, Kalaitzakis E, Kaler J, Kaplan S, Kostoulas P, Kovalenko K, Kneževič N, Knific T, Koleci X, Madouasse A, Malakauskas A, Mandelik R, Meletis E, Mincu M, Mõtus K, Muñoz-Gómez V, Niculae M, Nikitović J, Ocepek M, Tangen-Opsal M, Ózsvári L, Papadopoulos D, Papadopoulos T, Pelkonen S, Polak MP, Pozzato N, Rapaliuté E, Ribbens S, Niza-Ribeiro J, Roch FF, Rosenbaum Nielsen L, Saez JL, Nielsen SS, van Schaik G, Schwan E, Sekovska B, Starič J, Strain S, Šatran P, Šerić-Haračić S, Tamminen LM, Thulke HH, Toplak I, Tuunainen E, Verner S, Vilček Š, Yildiz R, Santman-Berends IMGA. Overview of Cattle Diseases Listed Under Category C, D or E in the Animal Health Law for Which Control Programmes Are in Place Within Europe. Front Vet Sci. 2021 Jul 30;8:688078. doi: 10.3389/fvets.2021.688078. eCollection 2021. PMID: 34395571; PMCID: PMC8361752.
Copy Download .nbib Format: NLM
DNA sequencing of cytopathologically inconclusive EUS-FNA from solid pancreatic lesions suspicious for malignancy confirms EUS diagnosis.

Endoscopic ultrasound

Plougmann JI, Klausen P, Toxvaerd A, Abedi AA, Kovacevic B, Karstensen JG, Poulsen TS, Kalaitzakis E, Høgdall E, Vilmann P.
PMID: 31552911
Endosc Ultrasound. 2020 Jan-Feb;9(1):37-44. doi: 10.4103/eus.eus_36_19.

BACKGROUND AND OBJECTIVES: EUS-FNA is inconclusive in up to 10%-15% of patients with solid pancreatic lesions (SPLs). We aimed to investigate whether supplementary genetic analyses with whole-exome sequencing add diagnostic value in patients with SPLs suspicious of malignancy but...

Cite
Plougmann JI, Klausen P, Toxvaerd A, et al. DNA sequencing of cytopathologically inconclusive EUS-FNA from solid pancreatic lesions suspicious for malignancy confirms EUS diagnosis. Endosc Ultrasound. 2020;9(1):37-44doi: 10.4103/eus.eus_36_19.
Plougmann, J. I., Klausen, P., Toxvaerd, A., Abedi, A. A., Kovacevic, B., Karstensen, J. G., Poulsen, T. S., Kalaitzakis, E., Høgdall, E., & Vilmann, P. (2020). DNA sequencing of cytopathologically inconclusive EUS-FNA from solid pancreatic lesions suspicious for malignancy confirms EUS diagnosis. Endoscopic ultrasound, 9(1), 37-44. https://doi.org/10.4103/eus.eus_36_19
Plougmann, Julie Isabelle, et al. "DNA sequencing of cytopathologically inconclusive EUS-FNA from solid pancreatic lesions suspicious for malignancy confirms EUS diagnosis." Endoscopic ultrasound vol. 9,1 (2020): 37-44. doi: https://doi.org/10.4103/eus.eus_36_19
Plougmann JI, Klausen P, Toxvaerd A, Abedi AA, Kovacevic B, Karstensen JG, Poulsen TS, Kalaitzakis E, Høgdall E, Vilmann P. DNA sequencing of cytopathologically inconclusive EUS-FNA from solid pancreatic lesions suspicious for malignancy confirms EUS diagnosis. Endosc Ultrasound. 2020 Jan-Feb;9(1):37-44. doi: 10.4103/eus.eus_36_19. PMID: 31552911; PMCID: PMC7038737.
Copy Download .nbib Format: NLM
The Power of Triplet and Singlet Oxygen in Synthesis: 2-Oxindoles, 3-Hydroxy-2-oxindoles, and Isatins from Furans.

Organic letters

Triantafyllakis M, Sfakianaki K, Kalaitzakis D, Vassilikogiannakis G.
PMID: 29792439
Org Lett. 2018 Jun 15;20(12):3631-3634. doi: 10.1021/acs.orglett.8b01404. Epub 2018 May 24.

A straightforward synthesis of substituted 2-oxindoles, 3-hydroxy-2-oxindoles, and isatins has been developed. Easily accessible furans were transformed into tetrahydropyranopyrrolones by a singlet oxygen initiated cascade reaction sequence. An acid-catalyzed rearrangement, followed by aromatization, gave access to a variety of...

Cite
Triantafyllakis M, Sfakianaki K, Kalaitzakis D, et al. The Power of Triplet and Singlet Oxygen in Synthesis: 2-Oxindoles, 3-Hydroxy-2-oxindoles, and Isatins from Furans. Org Lett. 2018;20(12):3631-3634doi: 10.1021/acs.orglett.8b01404.
Triantafyllakis, M., Sfakianaki, K., Kalaitzakis, D., & Vassilikogiannakis, G. (2018). The Power of Triplet and Singlet Oxygen in Synthesis: 2-Oxindoles, 3-Hydroxy-2-oxindoles, and Isatins from Furans. Organic letters, 20(12), 3631-3634. https://doi.org/10.1021/acs.orglett.8b01404
Triantafyllakis, Myron, et al. "The Power of Triplet and Singlet Oxygen in Synthesis: 2-Oxindoles, 3-Hydroxy-2-oxindoles, and Isatins from Furans." Organic letters vol. 20,12 (2018): 3631-3634. doi: https://doi.org/10.1021/acs.orglett.8b01404
Triantafyllakis M, Sfakianaki K, Kalaitzakis D, Vassilikogiannakis G. The Power of Triplet and Singlet Oxygen in Synthesis: 2-Oxindoles, 3-Hydroxy-2-oxindoles, and Isatins from Furans. Org Lett. 2018 Jun 15;20(12):3631-3634. doi: 10.1021/acs.orglett.8b01404. Epub 2018 May 24. PMID: 29792439.
Copy Download .nbib Format: NLM
Predicting what can go wrong at endoscopic ultrasound: a large series experience.

Frontline gastroenterology

Kalaitzakis E, Varytimiadis K, Meenan J.
PMID: 28839592
Frontline Gastroenterol. 2011 Apr;2(2):110-116. doi: 10.1136/fg.2010.002980. Epub 2010 Nov 20.

OBJECTIVE: Although prior studies have evaluated complications following endoscopic ultrasound (EUS), data on the incidence of unplanned events at EUS, defined as any deviation from the preprocedure plan, are lacking. The aim of this study was to define the...

Cite
Kalaitzakis E, Varytimiadis K, Meenan J. Predicting what can go wrong at endoscopic ultrasound: a large series experience. Frontline Gastroenterol. 2010;2(2):110-116doi: 10.1136/fg.2010.002980.
Kalaitzakis, E., Varytimiadis, K., & Meenan, J. (2011). Predicting what can go wrong at endoscopic ultrasound: a large series experience. Frontline gastroenterology, 2(2), 110-116. https://doi.org/10.1136/fg.2010.002980
Kalaitzakis, Evangelos, et al. "Predicting what can go wrong at endoscopic ultrasound: a large series experience." Frontline gastroenterology vol. 2,2 (2011): 110-116. doi: https://doi.org/10.1136/fg.2010.002980
Kalaitzakis E, Varytimiadis K, Meenan J. Predicting what can go wrong at endoscopic ultrasound: a large series experience. Frontline Gastroenterol. 2011 Apr;2(2):110-116. doi: 10.1136/fg.2010.002980. Epub 2010 Nov 20. PMID: 28839592; PMCID: PMC5517208.
Copy Download .nbib Format: NLM
First Total Synthesis of Pandamarine.

Organic letters

Kalaitzakis D, Noutsias D, Vassilikogiannakis G.
PMID: 26126132
Org Lett. 2015 Jul 17;17(14):3596-9. doi: 10.1021/acs.orglett.5b01693. Epub 2015 Jun 30.

The first total synthesis of pandamarine, an alkaloid isolated from Pandanus amaryllifolius is reported. The key step of this extremely short (six steps in total) and protecting group-free synthesis is a highly efficient cascade reaction sequence initiated by the...

Cite
Kalaitzakis D, Noutsias D, Vassilikogiannakis G. First Total Synthesis of Pandamarine. Org Lett. 2015;17(14):3596-9doi: 10.1021/acs.orglett.5b01693.
Kalaitzakis, D., Noutsias, D., & Vassilikogiannakis, G. (2015). First Total Synthesis of Pandamarine. Organic letters, 17(14), 3596-9. https://doi.org/10.1021/acs.orglett.5b01693
Kalaitzakis, Dimitris, et al. "First Total Synthesis of Pandamarine." Organic letters vol. 17,14 (2015): 3596-9. doi: https://doi.org/10.1021/acs.orglett.5b01693
Kalaitzakis D, Noutsias D, Vassilikogiannakis G. First Total Synthesis of Pandamarine. Org Lett. 2015 Jul 17;17(14):3596-9. doi: 10.1021/acs.orglett.5b01693. Epub 2015 Jun 30. PMID: 26126132.
Copy Download .nbib Format: NLM
[No title available]

Pathogens (Basel, Switzerland)

Kalaitzakis E, Fancello T, Simons X, Chaligiannis I, Tomaiuolo S, Andreopoulou M, Petrone D, Papapostolou A, Giadinis ND, Panousis N, Mori M.
PMID: 33802264
Pathogens. 2021 Mar 03;10(3). doi: 10.3390/pathogens10030287.

Ruminants are considered the commonest animal reservoir for human infection of

Cite
Kalaitzakis E, Fancello T, Simons X, et al. . Pathogens. 2021;10(3)doi: 10.3390/pathogens10030287.
Kalaitzakis, E., Fancello, T., Simons, X., Chaligiannis, I., Tomaiuolo, S., Andreopoulou, M., Petrone, D., Papapostolou, A., Giadinis, N. D., Panousis, N., & Mori, M. (2021). . Pathogens (Basel, Switzerland), 10(3), . https://doi.org/10.3390/pathogens10030287
Kalaitzakis, Emmanouil, et al. "." Pathogens (Basel, Switzerland) vol. 10,3 (2021). doi: https://doi.org/10.3390/pathogens10030287
Kalaitzakis E, Fancello T, Simons X, Chaligiannis I, Tomaiuolo S, Andreopoulou M, Petrone D, Papapostolou A, Giadinis ND, Panousis N, Mori M. . Pathogens. 2021 Mar 03;10(3). doi: 10.3390/pathogens10030287. PMID: 33802264; PMCID: PMC7998660.
Copy Download .nbib Format: NLM
Eosin: a versatile organic dye whose synthetic uses keep expanding.

Organic & biomolecular chemistry

Bosveli A, Montagnon T, Kalaitzakis D, Vassilikogiannakis G.
PMID: 33899893
Org Biomol Chem. 2021 Apr 26;19(15):3303-3317. doi: 10.1039/d1ob00301a.

Organic dyes, which absorb light in the visible region of the electromagnetic spectrum, offer a lower cost, greener alternative to precious metals in photocatalysis. In this context, the organic dye eosin's uses are currently expanding at a significant rate....

Cite
Bosveli A, Montagnon T, Kalaitzakis D, et al. Eosin: a versatile organic dye whose synthetic uses keep expanding. Org Biomol Chem. 2021;19(15):3303-3317doi: 10.1039/d1ob00301a.
Bosveli, A., Montagnon, T., Kalaitzakis, D., & Vassilikogiannakis, G. (2021). Eosin: a versatile organic dye whose synthetic uses keep expanding. Organic & biomolecular chemistry, 19(15), 3303-3317. https://doi.org/10.1039/d1ob00301a
Bosveli, Artemis, et al. "Eosin: a versatile organic dye whose synthetic uses keep expanding." Organic & biomolecular chemistry vol. 19,15 (2021): 3303-3317. doi: https://doi.org/10.1039/d1ob00301a
Bosveli A, Montagnon T, Kalaitzakis D, Vassilikogiannakis G. Eosin: a versatile organic dye whose synthetic uses keep expanding. Org Biomol Chem. 2021 Apr 26;19(15):3303-3317. doi: 10.1039/d1ob00301a. PMID: 33899893.
Copy Download .nbib Format: NLM
Existence and Quality of Data on Control Programs for EU Non-regulated Cattle Diseases: Consequences for Estimation and Comparison of the Probability of Freedom From Infection.

Frontiers in veterinary science

Rapaliute E, van Roon A, van Schaik G, Santman-Berends I, Koleci X, Mincu M, Gethmann J, Conrady B, Knific T, Hodnik JJ, Berezowski J, Carmo LP, Madouasse A, Tarpai A, Gerilovych A, Malakauskas A, Sekovska B, Fourichon C, Kalaitzakis E, Roch FF, Houe H, Dudek K, Mõtus K, Ózsvári L, Costa L, Guelbenzu-Gonzalo M, Henry MK, Alishani M, Pozzato N, Hopp P, Juste R, Strain S, Mandelik R, Vilček Š, Autio T, Tamminen LM, Faverjon C.
PMID: 34350229
Front Vet Sci. 2021 Jul 19;8:689375. doi: 10.3389/fvets.2021.689375. eCollection 2021.

Some European countries have successfully implemented country-specific control programs (CPs) for infectious cattle diseases that are not regulated or are regulated only to a limited extent at the European Union (EU) level. Examples of such diseases include bovine viral...

Cite
Rapaliute E, van Roon A, van Schaik G, et al. Existence and Quality of Data on Control Programs for EU Non-regulated Cattle Diseases: Consequences for Estimation and Comparison of the Probability of Freedom From Infection. Front Vet Sci. 2021;8:689375doi: 10.3389/fvets.2021.689375.
Rapaliute, E., van Roon, A., van Schaik, G., Santman-Berends, I., Koleci, X., Mincu, M., Gethmann, J., Conrady, B., Knific, T., Hodnik, J. J., Berezowski, J., Carmo, L. P., Madouasse, A., Tarpai, A., Gerilovych, A., Malakauskas, A., Sekovska, B., Fourichon, C., Kalaitzakis, E., Roch, F. F., Houe, H., Dudek, K., Mõtus, K., Ózsvári, L., Costa, L., Guelbenzu-Gonzalo, M., Henry, M. K., Alishani, M., Pozzato, N., Hopp, P., Juste, R., Strain, S., Mandelik, R., Vilček, �. �., Autio, T., Tamminen, L. M., & Faverjon, C. (2021). Existence and Quality of Data on Control Programs for EU Non-regulated Cattle Diseases: Consequences for Estimation and Comparison of the Probability of Freedom From Infection. Frontiers in veterinary science, 8689375. https://doi.org/10.3389/fvets.2021.689375
Rapaliute, Egle, et al. "Existence and Quality of Data on Control Programs for EU Non-regulated Cattle Diseases: Consequences for Estimation and Comparison of the Probability of Freedom From Infection." Frontiers in veterinary science vol. 8 (2021): 689375. doi: https://doi.org/10.3389/fvets.2021.689375
Rapaliute E, van Roon A, van Schaik G, Santman-Berends I, Koleci X, Mincu M, Gethmann J, Conrady B, Knific T, Hodnik JJ, Berezowski J, Carmo LP, Madouasse A, Tarpai A, Gerilovych A, Malakauskas A, Sekovska B, Fourichon C, Kalaitzakis E, Roch FF, Houe H, Dudek K, Mõtus K, Ózsvári L, Costa L, Guelbenzu-Gonzalo M, Henry MK, Alishani M, Pozzato N, Hopp P, Juste R, Strain S, Mandelik R, Vilček Š, Autio T, Tamminen LM, Faverjon C. Existence and Quality of Data on Control Programs for EU Non-regulated Cattle Diseases: Consequences for Estimation and Comparison of the Probability of Freedom From Infection. Front Vet Sci. 2021 Jul 19;8:689375. doi: 10.3389/fvets.2021.689375. eCollection 2021. PMID: 34350229; PMCID: PMC8328145.
Copy Download .nbib Format: NLM
Ischemic Pancreatitis Is an Important Cause of Acute Pancreatitis in the Intensive Care Unit.

Journal of clinical gastroenterology

Baldursdottir MB, Andresson JA, Jonsdottir S, Benediktsson H, Kalaitzakis E, Bjornsson ES.
PMID: 34974492
J Clin Gastroenterol. 2021 Dec 31; doi: 10.1097/MCG.0000000000001651. Epub 2021 Dec 31.

BACKGROUND: Ischemic pancreatitis (IP) has mainly been described in case reports. The aims of the study were to assess the frequency, clinical characteristics and outcomes in patients with IP among patients hospitalized in the intensive care unit (ICU) for...

Cite
Baldursdottir MB, Andresson JA, Jonsdottir S, et al. Ischemic Pancreatitis Is an Important Cause of Acute Pancreatitis in the Intensive Care Unit. J Clin Gastroenterol. 2021;doi: 10.1097/MCG.0000000000001651.
Baldursdottir, M. B., Andresson, J. A., Jonsdottir, S., Benediktsson, H., Kalaitzakis, E., & Bjornsson, E. S. (2021). Ischemic Pancreatitis Is an Important Cause of Acute Pancreatitis in the Intensive Care Unit. Journal of clinical gastroenterology, . https://doi.org/10.1097/MCG.0000000000001651
Baldursdottir, Maria B, et al. "Ischemic Pancreatitis Is an Important Cause of Acute Pancreatitis in the Intensive Care Unit." Journal of clinical gastroenterology vol. (2021). doi: https://doi.org/10.1097/MCG.0000000000001651
Baldursdottir MB, Andresson JA, Jonsdottir S, Benediktsson H, Kalaitzakis E, Bjornsson ES. Ischemic Pancreatitis Is an Important Cause of Acute Pancreatitis in the Intensive Care Unit. J Clin Gastroenterol. 2021 Dec 31; doi: 10.1097/MCG.0000000000001651. Epub 2021 Dec 31. PMID: 34974492.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 48 entries